Previous Article | Next Article ![]()
Infection and Immunity, April 2001, p. 2596-2603, Vol. 69, No. 4
Department of Pathology and Laboratory
Medicine, University of Wisconsin Medical School, Madison, Wisconsin
Received 28 September 2000/Returned for modification 6 December
2000/Accepted 4 January 2001
Progressive granuloma formation is a hallmark of chronic
mycobacterial infection. Granulomas are localized, protective
inflammatory reactions initiated by CD4+ T cells, which
contribute to control of bacterial growth and blockade of bacterial
dissemination. In order to understand the costimulatory requirements
that allow CD4+ T cells to directly or indirectly induce
granulomas, we studied granuloma formation after 6 weeks in
Mycobacterium bovis BCG-infected CD28- and CD40 ligand
(CD40L)-deficient mice and compared it to granuloma formation in
infected wild-type inbred mice and infected cytokine-deficient mice. We
characterized granulomas morphologically in liver sections, analyzed
granuloma infiltrating cells by flow cytometry, and measured cytokine
production by cultured granuloma cells. CD28-deficient mice have no
defect at the local inflammatory site, inasmuch as they form protective
granulomas and control bacterial growth. However, there are fewer
activated T cells in the spleen compared to infected wild-type animals,
and quantitative differences in the cellular composition of the
granuloma are observed by flow cytometry. In CD40L-deficient mice, the
granuloma phenotype is very similar to the phenotype in gamma
interferon (IFN- Granuloma formation around infected
macrophage is a defining cellular response to mycobacterium infections.
Layers of extracellular matrix enclose a microenvironment of infected
cells and an intense inflammatory infiltrate. Granulomas eliminate
bacteria and also protect surrounding host tissue from destructive
inflammatory responses. Without granuloma formation, mycobacterial
infections can become widely disseminated and frequently lethal, as
occurs in human AIDS-associated tuberculosis or in the infection of
SCID or recombinase-activating gene-deficient mice (22, 27, 33, 34). The involvement of T lymphocytes in initiation, regulation, and resolution of granuloma formation has been well documented for both
human and murine infections (18, 22).
Murine models of Mycobacterium tuberculosis and
Mycobacterium bovis infection have been used to study the
role of cytokine regulatory networks in T lymphocyte-macrophage
interactions (11). Mycobacterial infections induce a
Th1-type T-cell response in which gamma interferon (IFN- In this study, we examined the role of CD28 and the role of CD40-CD40L
for M. bovis bacille Calmette-Guérin (BCG)-induced protective granuloma formation. We took advantage of the availability of both CD28 and CD40L gene knockout mice to compare their roles in
generating the cytokine milieu required for effective granulomatous immune responses. Additionally, we focused on characterizing the effector T-lymphocyte activation phenotype and function in the granuloma in the absence of specific costimulatory molecules and correlated that with control of bacterial dissemination and formation of effective granulomas as assessed by quantitative histopathology. Here we report that there is a striking change in the granuloma phenotype of CD40L knockout mice after intraperitoneal infection with
BCG. Our data suggest that CD40L costimulatory function, but not CD28
function, is essential for the generation of IFN- Animals.
In these studies we used C57BL/6, IFN- M. bovis BCG infections.
BCG (substrain Pasteur,
from G. Fennelly) was grown in Middlebrook 7H9 (Difco Laboratories,
Detroit, Mich.) with 0.05% Tween 80 and 10% oleic
acid-dextrose-catalase (OADC) (Difco) supplement and stored in frozen
aliquots at Histology.
Small pieces of liver were fixed in 10% formalin
prior to being imbedded in paraffin for thin sectioning (8 to 10 µm).
Hematoxylin and eosin staining and Ziehl-Neelsen staining for acid-fast
bacteria were done by the Department of Pathology's Histopathology
Service, University of Wisconsin. Quantitative studies were performed
by direct microscopic examination using a Olympus reticular eyepiece containing a 10 by 10 grid. Liver granuloma burden is the number of
granulomas per grid in a field under 100× total magnification. Granuloma size is the number of grid squares covered at 400× total magnification. Bacteria per lesion is the number of acid-fast rods
visible per granuloma at 1,000× total magnification using an oil
immersion lens. Data are presented as the mean ± standard error
of the mean for a minimum of 30 counts per mouse liver section. The
number of individual mice is indicated in the figure legends.
Isolation of splenocytes and granuloma-infiltrating cells.
Isolation of granulomas is described in references 29, 36, and
38. Spleens were removed aseptically from 8- to 16-week-old mice, and viable cells were separated by centrifugation through Lympholyte M solution (Cedarlane Laboratories, Hornsby, Ontario, Canada) as described (35).
Flow cytometry and antibodies.
Splenocytes or granuloma cell
suspensions were incubated for 30 min at 4°C with different labeled
antibodies at saturation and then washed and analyzed. Unlabeled
anti-Fc receptor antibody 2.4G2 (50 µg/ml) was used to block
nonspecific binding of Fc receptors. Cell surface staining on 10,000 events was measured by fluorescence-activated cell sorting (FACS)
on a FACS Calibur (Becton Dickinson) and analyzed using the Cellquest
computer program (Power Macintosh version 3.0; Becton Dickinson).
0019-9567/01/$04.00+0 DOI: 10.1128/IAI.69.4.2596-2603.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Mycobacterium bovis BCG-Induced Granuloma Formation
Depends on Gamma Interferon and CD40 Ligand but Does Not
Require CD28

![]()
ABSTRACT
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
)-deficient mice. Both IFN-
-deficient and
CD40L-deficient mice form granulomas which prevent bacterial
dissemination, but control of bacterial growth is significantly
impaired. The relative proportion of CD4+ T cells in
granulomas from both CD28
/
and CD40L
/
mice is significantly decreased compared with wild-type animals. Both
models demonstrate that the phenotype and activation stage of systemic
T cells do not always correlate with the phenotype and activation stage
of the localized granulomatous response.
![]()
INTRODUCTION
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
) and tumor
necrosis factor alpha (TNF-
) play crucial roles in granuloma
formation and function (6, 9, 21, 23, 30, 39). In contrast
to the extensive characterization of cytokine requirements for
protective granuloma formation, the study of essential T-cell
costimulatory signaling is relatively new. The role of CD28 has not
been studied, and the role of CD40-CD40 ligand (CD40L) interactions in
protection against mycobacterial infection is controversial. One recent
study reported that the CD40L-mediated pathway of T-cell activation is
dispensable for resistance to M. tuberculosis infection
(4). This was in contrast to the enhanced susceptibility
to infection observed clinically in patients with a defective CD40L
gene (2, 45) and to other experimental infections with
intracellular pathogens, including Leishmania (3, 20,
43).
levels adequate
for the control of mycobacterial replication at the local inflammatory
site. This is consistent with a model in which CD40L-mediated
interactions are essential for the induction of a strong Th1 immune
response to intracellular pathogens. We show that both CD40L-CD40 and
CD28-B7 interactions influence the cellular composition of granulomas
and demonstrate that the systemic T-cell response does not closely
correlate with the T-cell response detected in the local inflammatory lesion.
![]()
MATERIALS AND METHODS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
gene-deficient, TNF-
gene deficient, CD28 gene-deficient, and CD40L
gene-deficient strains of mice purchased from Jackson Labs. Animals
were housed at animal facilities at both the University of Wisconsin
Medical School and the William S. Middleton Memorial Veterans
Administration Hospital. Both facilities are accredited and meet Public
Health Service policy.
70°C. For infections, ampoules were thawed, and the
inoculum was diluted in saline plus 0.05% Tween 80 and briefly exposed
to sonic oscillation in order to obtain a single-cell suspension. Mice
were infected intraperitoneally with 107 BOG in 100 µl
(12) in order to maximize the production of liver granulomas. The dose injected is not lethal and induces a disease that
is cleared with time. Infection was verified by histology of liver
tissue samples. We chose liver granulomas for analysis because they can
be isolated in larger numbers free of surrounding tissue than lung granulomas.
/
(
/
TCR) and CD4
were from Sigma Chemical Co. (St. Louis, Mo.) and against murine major
histocompatibility complex (MHC) class II (
I-Ab) and NK
cells were from Pharmingen (San Diego, Calif.).
Cytokine measurements.
Samples for cytokine analysis were
collected from 106 liver granuloma cells or spleen cells
(live by trypan blue exclusion) seeded into 96-well plates in 0.2 ml of
complete medium and stimulated with 10 µg of
-CD3 antibody per ml.
After 72 h, cell culture supernatants were harvested and stored at
70°C until testing. Measurement of secreted IFN-
was made by
enzyme-linked immunosorbent assay (ELISA) using standard methods.
Briefly, plates were coated with anti-IFN-
capture antibody
(Pharmingen). Serial twofold dilutions of either murine recombinant
IFN-
(rIFN-
) (Genzyme, Cambridge, Mass.) or test supernatants
were added to triplicate wells. Bound cytokine was detected with
biotinylated anti-mouse IFN-
(Pharmingen) followed by avidin
phosphatase (Molecular Probes, Eugene, Oreg.). Wells were developed
with 50 µM 4-methylumbelliferyl phosphate (Molecular Probes), and
fluorescence intensity was measured with an HTS7000 Bioassay reader
(Perkin Elmer, Foster City, Calif.). Units of IFN-
were calculated
with reference to the rIFN
standard. All data are expressed as the
amount of secreted cytokine per 106 cells.
Organ load. Bacterial colony formation was determined by plating serial dilutions of liver homogenates on Middlebrook 7H10 agar plates (Difco) supplemented with 10% OADC and cycloheximide (10 µg/ml). Colonies were counted after 3 weeks of incubation at 37°C.
| |
RESULTS |
|---|
|
|
|---|
Liver histopathology.
To examine the T-cell costimulatory
requirements for protective granuloma formation in the liver, we
infected CD40L and CD28 gene-deficient mice with BCG. At 6 weeks, when
a chronic infection had been established, we sacrificed the mice and
examined thin liver sections for granuloma formation. Figure
1 shows that CD28-deficient mice can form
adequate numbers of well-formed lesions similar to those found in
C57BL/6 mice (compare Fig. 1B and 1A). Staining for acid-fast bacteria
illustrates that the extent of infection found within individual
granulomas is also very similar to that seen in the wild-type mice
(compare 1L with 1K). This is in stark contrast to the CD40L-deficient
mice, which have substantially more bacteria present per lesion (Fig.
1M). These sections were compared to the histopathology observed after
infection of IFN-
- and TNF-
-deficient mice (Fig. 1D, E, I, J, N,
and O). Both IFN-
and TNF-
are known to be essential for
protective immunity against mycobacterial infection. IFN-
-deficient
mice have elevated numbers of bacteria present within lesions, but
there are well-formed granulomas and the surrounding tissue is healthy
(Fig. 1D, I, and N). In contrast, TNF-
-deficient mice form very
large, poorly organized lesions which do not effectively contain the
bacterial infection (Fig. 1E, J, and O). Bacteria and infected
macrophage are observed which have no surrounding inflammation. The
extensive bacterial dissemination and organ damage associated with this response was repeatedly lethal before 6 weeks: the TNF-
section illustrated in Fig. 1 is from a 4-week infection. The tissue pathology that we observed with the CD40L-deficient mice is hence very similar to
that of the IFN-
-deficient mice (compare Fig. 1H to I and 1M to N).
Both have good granuloma structures but poor control of bacteria,
suggesting that CD40L
/
mice may be deficient in IFN-
but provide sufficient TNF-
. Histopathology in CD28
/
mice is comparable to that in wild-type mice.
|
-deficient mice are larger
and more numerous than wild-type granulomas and are very comparable
to the granulomas of CD40L-deficient mice. The number of bacteria per
lesion in IFN-
-deficient mice is almost 13 times higher than the
number of bacteria in wild-type lesions. The data suggest that IFN-
and CD40L but not CD28 are crucial for effective granuloma formation
and bacterial killing. Data from TNF-
-deficient mice are not
presented due both to the significantly smaller sample size and to the
fact that the lesions are so disorganized as to make the comparison
questionable. Identical trends were seen in bacterial load measurements
made by plating liver homogenates and calculating CFU per liver (Fig.
2, last panel).
|
Comparison of T-cell accumulation and T-cell phenotype between
local inflammatory site and spleen.
Flow cytometry was used to
measure the phenotype and cell surface marker expression of cell
populations found in spleen and in liver granulomas after 6 weeks of
BCG infection. Figure 3A shows that
CD40L-deficient mice have a significant reduction in the relative
proportion of CD4+ T cells present in
granuloma-infiltrating cells compared to both C57BL/6 and
CD28-deficient mice (third row compared to first and second rows).
Combined CD44 and CD62L (L-selectin) antibody staining indicates that
activation (CD44 high, CD62L low) of both CD4+ and
CD8+ T cells is unimpaired. The absolute number of
CD4+ T cells on a per-liver basis might be unchanged or
even larger, since Fig. 2 showed that CD40L-deficient mice have more
and larger granulomas, but the CD4+ T cells are
proportionally fewer in the lesions. The lower level of MHC class II
molecules on macrophage populations likely indicates a lower local
concentration of IFN-
in the granulomatous lesion. That correlates
well with the abolished bacterial control shown in Fig. 1 and 2. We
conclude that in the absence of CD40L expression on T cells,
insufficient numbers of activated CD4+ T cells capable of
secreting IFN-
home to local inflammatory sites. The phenotype of
CD28-deficient granuloma cells is almost indistinguishable from that of
C57BL/6 granuloma cells with the exception that a smaller percentage of
CD8+ T cells is observed in both CD28-deficient mice and
CD40L-deficient mice (first column, 24.8% versus 14.3% and 15.2%,
respectively).
|
/
TCR-specific antibodies. Figure
4 shows the relative accumulation of
these cell types in C57BL/6 and CD28-deficient mouse granulomas. NK
cell numbers in the spleen of CD28-deficient mice were just slightly
lower than in wild-type and CD40L
/
mice (data not
shown). This suggests that although NK cells and NK T cells may play a
role in antimycobacterial control in granulomas, other mechanisms are
able to compensate adequately for their absence.
|
IFN-
measurements.
The capacity of BCG-induced
granuloma-infiltrating cells to produce IFN-
was measured directly
by ELISA of cell culture supernatants. As expected, the amount of
IFN-
produced by granuloma cells from CD40L-deficient mice after 3 days of in vitro stimulation by
-CD3 antibody was below the assay
sensitivity and hence significantly lower (P < 0.05,
Student's t test) than levels produced by granuloma cells
from C57BL/6 or CD28-deficient mice (Fig.
5A). IFN-
levels produced by
CD28-deficient mouse splenocytes similarly stimulated with
-CD3
antibody were 5- to 10-fold lower than those from CD40L-deficient or
C57BL/6 mouse stimulated splenocytes, respectively (Fig. 5B). The
overall level of IFN-
detected in granuloma cell culture supernatants was less than in splenocyte culture supernatants. The
comparable expression of MHC class II molecules on macrophages from
C57BL/6 infected animals in either compartment makes it unlikely that
the difference reflects differences in vivo (Fig. 3A and B). We must
consider that although we used similar cell numbers in culture, there
may be a greater fraction of T cells present in total splenocytes than
in granuloma cell preparations (~10 to 15%). Additionally, the
viability of granuloma cells in culture may be lower than the viability
of spleen cells.
|
| |
DISCUSSION |
|---|
|
|
|---|
The essential role of CD4+ T cells in granuloma
formation in response to intracellular and extracellular mycobacteria
is undisputed. BCG infection of class II-deficient mice showed that
without CD4+ T cells, infected and dying macrophages
recruit a damaging neutrophilic inflammatory response that is unable to
control bacterial replication (26). T cells, their
directly elaborated cytokines, and cytokines from activated macrophage
are essential both for forming a protective structure to contain the
inflammatory response and for eradicating the sequestered bacteria.
Mice deficient in IFN-
or cytokines that regulate IFN-
levels,
including Eta-1 (osteopontin) (1, 31), and interleukin-12
(IL-12) (7, 19), cannot control bacterial growth. In the
absence of TNF-
, inflammation is uncontrolled and tissue-damaging
abscesses are formed (10, 23, 39).
In this study we examined the costimulatory signal requirements for
activation of CD4+ T cells to regulate sufficient
production of IFN-
and TNF-
to form protective granulomas in
response to chronic BCG infection. To our knowledge, this is the only
study to directly examine the phenotype of cells that accumulate in
BCG-induced granulomas and correlate that phenotype to protective
histopathology. In the absence of costimulatory molecules, our data
demonstrated that there can be substantial differences between splenic
responses and local responses at the granulomatous inflammatory site.
CD40L upregulation after TCR engagement is linked to a cascade of
events, including production of cytokines and chemokines, significantly
IFN-
and TNF-
in the case of mycobacteria, and increased
expression of accessory molecules on antigen-presenting cells. Recent
studies have suggested that CD28-mediated signals are not always
required for resistance to various infections, but instead are
important for the optimal production of IL-2 and IFN-
and/or good
memory responses (13, 25, 44). Autocrine production of
IL-2 after initial CD28 costimulation can sustain CD40L expression in
the absence of CD28 or TCR signaling (41). This may
represent an important mechanism for reactivating previously stimulated
T cells in the absence of antigen. Since our work has shown that CD28
and IL-2 are not essential for protective granuloma formation (data not
shown), it seems likely that the requirement for CD40L expression in
BCG-induced granuloma formation is not dependent upon CD28 engagement
and IL-2 signaling. Our data suggest an alternative model in which
CD40L-mediated costimulation is required to produce sufficient IFN-
locally. The evidence for this includes the qualitative and
quantitative similarity of histopathology between CD40L-deficient and
IFN-
-deficient mice (Fig. 1 and 2). Additionally, IFN-
levels are
greatly depressed in granuloma culture supernatants from
CD40L-deficient mice (Fig. 5), and MHC class II expression is reduced
on granuloma-infiltrating macrophages from these mice (Fig. 3),
suggesting that the amount of IFN3-
in the granuloma is not
sufficient for normal macrophage activation. A correlation between
CD40L expression and IFN-
production after mycobacterial infection
has also been shown by clinical studies of peripheral blood mononuclear
cells (PBMCs) from tuberculosis patients and healthy tuberculin
reactors (37). It is also clear from our data that
sufficient TNF-
is available without CD40L or CD28, as the extensive
and damaging inflammation that results in early death in
TNF-
-deficient animals is not seen (Fig. 1).
Our flow cytometric data also showed that in the absence of CD40L,
CD4+ T-cell recruitment to the local inflammatory site is
substantially reduced (Fig. 3). However, there are activated T cells in
the spleens of BCG-infected CD40L-deficient mice. Since activated T
cells are capable of homing to local inflammatory sites, it is likely
that CD4+ T-cell accumulation in the granuloma is regulated
not only at the level of T-cell activation, but also by other factors
such as motility, extravasation, recruitment or chemotactic
sensitivity. The cellular composition of granulomas in
CD40L
/
mice indicated that recruitment of both
CD4+ and CD8+ T cells is altered.
Although previous immunohistochemical studies have shown that human
tuberculoid granulomatous lesions contain readily detectable levels of
B7-1 and B7-2 on epithelioid cells and of CD28 on T cells
(42), our data indicated that CD28 is dispensable for protective granulomatous responses against BCG in a murine model. T
cells from CD28-deficient mice have reduced expression of IL-2 receptor
(IL-2R
), reduced T-helper cell function, and reduced proliferation to concanavalin A but are still able to mount an effective anti-lymphocytic choriomeningitis virus cytolytic immune response in vivo (40). Although resistance to primary
infection by Schistosoma mansoni is impaired in
CD28-deficient mice (24), and Th2 protective responses are
diminished, egg-induced granulomatous reactions in the livers of these
mice are unaffected. Similarly, B7-1/2
/
mice also form
intact granulomas around schistosome eggs despite limited T-cell
proliferative capacity and a skew towards Th1-type cytokine production
(15).
The results of our study suggested that costimulation mediated by
either CD40L or other accessory molecules can compensate for the lack
of CD28 during the local response to BCG. In the microenvironment of
the granuloma, local concentrations of IL-15 and IL-12 may be
sufficient to maintain CD40L expression (41) and drive
IFN-
production (44) independent of CD28. Bacteria within granulomas may also alter costimulatory requirements relative to
the periphery due to higher local concentrations of antigen (25). Although CD28-mediated signaling was not required at
the local inflammatory site, the systemic response to BCG infection was
much lower, perhaps reflecting either reduced systemic T-cell activation or complete recruitment of the few systemically activated T
cells to the local inflammatory site.
The mechanisms responsible for the somewhat lower proportions of
CD8+ T cells and the absence of NK cells and NK T cells
found in granuloma cell populations from BCG-infected
CD28
/
mice are not understood. Since NK cells are
activated by CD28 (5, 17), one explanation is that
activation is required for NK cell recruitment to the granuloma. Our
data suggest that NK and NK T cells are not absolutely essential for
protective granuloma formation. Additionally, our study makes
it clear that the peripheral spleen cell phenotype is not a sure
predictor of either granuloma formation or granuloma-infiltrating cell
phenotype and underscores the importance of examining the granuloma
cells directly.
Our data regarding the susceptibility of CD40L-deficient mice to BCG
infection is contrary to the published reports of Campos-Neto using
intravenous infection with M. tuberculosis (4),
but consistent with the overall agreement among infection studies
regarding the role of CD40L (3, 8, 20, 43, 46, 48). The
results of their study were surprising given that cell lines
transfected with CD40L genes gain the ability to inhibit the growth of
M. avium in human monocyte-derived macrophages in vitro
(14). Samten et al. also presented data that CD40L
disregulation contributes to reduced IFN-
production in PBMCs from
tuberculosis patients (37). It has been shown that BCG
requires CD40L-CD40 interactions for the IL-12-regulated production of
IFN-
from human macrophages (28). Skin lesions from
resistant tuberculoid leprosy patients contain elevated levels of CD40
and CD40L mRNA and protein compared to those from susceptible
lepromatous patients (47).
The experimental differences between our work and the previous study include differences in the bacteria, the dosage, and the route of infection. Our experimental mice were infected at high dose intraperitoneally with BCG for the rapid induction of a chronic immune response and maximum liver granuloma formation. Villegas and coworkers (44) have reported differences in the requirement for CD40L between acute (CD40L independent) and chronic (CD40L dependent) stages of infection with Toxoplasma gondii. This difference might be mediated by differences in the initially predominant antigen-presenting cell population encountered via alternative infection routes, given that recent reports have demonstrated variable requirements for CD40-CD40L interactions in different subpopulations of antigen-presenting cells (32).
Delineating the requirement for CD40L-mediated costimulation for
granuloma formation has important consequences for our approach to
managing pathologic granulomatous diseases without an infectious etiology. In sarcoidosis and Crohn's disease, targeted immunotherapies to downregulate T-cell function may be beneficial. This type of approach is already being taken using anti-CD40L antibodies to treat
autoimmune demyelinating disease models in mice and has shown promising
results (16). Our data suggest that granuloma formation in
response to BCG can compensate for the loss of CD28 function and that
CD40L expression plays an antimycobacterial protective role via the
regulation of IFN-
. Additionally, the models strikingly show that
the status of systemic responses may not be reflected at local
inflammatory sites. Hence, the study of immune responses at local
lesions, like granulomas, deserves significantly more attention.
| |
ACKNOWLEDGMENTS |
|---|
This work was supported by an R01 award (AI 48087-01) from the National Institutes of Health, an American Lung Association award, and an institutional Howard Hughes award to M.S.
We thank Satoshi Kinoshita for his excellent histopathology services, Diane Sewell and Dominic Co for careful reading of the manuscript, and members of our laboratory for many helpful discussions.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Room 5580 MSC, 1300 University Ave., Madison, WI 53706. Phone: (608) 262-2577. Fax: (608) 265-3301. E-mail: lhhogan{at}facstaff.wisc.edu.
Present address: University of Heidelberg, Heidelberg, Germany.
Editor: J. D. Clements
| |
REFERENCES |
|---|
|
|
|---|
| 1. |
Ashkar, S.,
G. F. Weber,
V. Panoutsakopoulou,
M. E. Sanchirico,
M. Jansson,
S. Zawaideh,
S. R. Rittling,
D. T. Denhardt,
M. J. Glimcher, and H. Cantor.
2000.
Eta-1 (osteopontin): an early component of type-1 (cell-mediated) immunity.
Science
287:860-864 |
| 2. | Callard, R. E., R. J. Armitage, W. C. Fanslow, and M. K. Spriggs. 1993. CD40 ligand and its role in X-linked hyper-IgM syndrome. Immunol. Today 14:559-564[CrossRef][Medline]. |
| 3. | Campbell, K. A., P. J. Ovendale, M. K. Kennedy, W. C. Fanslow, S. G. Reed, and C. R. Maliszewski. 1996. CD40 ligand is required for protective cell-mediated immunity to Leishmania major. Immunity 4:283-289[CrossRef][Medline]. |
| 4. |
Campos-Neto, A.,
P. Ovendale,
T. Bement,
T. A. Koppi,
W. C. Fanslow,
M. A. Rossi, and M. R. Alderson.
1998.
CD40 ligand is not essential for the development of cell-mediated immunity and resistance to Mycobacterium tuberculosis.
J. Immunol.
160:2037-2041 |
| 5. | Chambers, B. J., M. Salcedo, and H. G. Ljunggren. 1996. Triggering of natural killer cells by the costimulatory molecule CD80 (B7-1). Immunity 5:311-317[CrossRef][Medline]. |
| 6. |
Cooper, A. M.,
D. K. Dalton,
T. A. Stewart,
J. P. Griffin,
D. G. Russell, and I. M. Orme.
1993.
Disseminated tuberculosis in interferon gamma gene-disrupted mice.
J. Exp. Med.
178:2243-2247 |
| 7. |
Cooper, A. M.,
J. Magram,
J. Ferrante, and I. M. Orme.
1997.
Interleukin 12 (IL-12) is crucial to the development of protective immunity in mice intravenously infected with mycobacterium tuberculosis.
J. Exp. Med.
186:39-45 |
| 8. |
Cosyns, M.,
S. Tsirkin,
M. Jones,
R. Flavell,
H. Kikutani, and A. R. Hayward.
1998.
Requirement of CD40-CD40 ligand interaction for elimination of Cryptosporidium parvum from mice.
Infect. Immun.
66:603-607 |
| 9. |
Dalton, D. K.,
S. Pitts-Meek,
S. Keshav,
I. S. Figari,
A. Bradley, and T. A. Stewart.
1993.
Multiple defects of immune cell function in mice with disrupted interferon- genes.
Science
259:1739-1742 |
| 10. |
Ehlers, S.,
J. Benini,
S. Kutsch,
R. Endres,
E. T. Rietschel, and K. Pfeffer.
1999.
Fatal granuloma necrosis without exacerbated mycobacterial growth in tumor necrosis factor receptor p55 gene-deficient mice intravenously infected with Mycobacterium avium.
Infect. Immun.
67:3571-3579 |
| 11. | Flesch, I. E., and S. H. Kaufmann. 1993. Role of cytokines in tuberculosis. Immunobiology 189:316-339[Medline]. |
| 12. |
Flynn, J. L.,
M. M. Goldstein,
J. Chan,
K. J. Triebold,
K. Pfeffer,
C. J. Lowenstein,
R. Schreiber,
T. W. Mak, and B. R. Bloom.
1995.
Tumor necrosis factor- is required in the protective immune response against Mycobacterium tuberculosis in mice.
Immunity
2:561-572[CrossRef][Medline].
|
| 13. | Gause, W. C., S. J. Chen, R. J. Greenwald, M. J. Halvorson, P. Lu, X. D. Zhou, S. C. Morris, K. P. Lee, C. H. June, F. D. Finkelman, J. F. Urban, and R. Abe. 1997. CD28 dependence of T cell differentiation to IL-4 production varies with the particular type 2 immune response. J. Immunol. 158:4082-4087[Abstract]. |
| 14. |
Hayashi, T.,
S. P. Rao,
P. R. Meylan,
R. S. Kornbluth, and A. Catanzaro.
1999.
Role of CD40 ligand in Mycobacterium avium infection.
Infect. Immun.
67:3558-3565 |
| 15. |
Hernandez, H. J.,
A. H. Sharpe, and M. J. Stadecker.
1999.
Experimental murine schistosomiasis in the absence of B7 costimulatory molecules: reversal of elicited T cell cytokine profile and partial inhibition of egg granuloma formation.
J. Immunol.
162:2884-2889 |
| 16. | Howard, L. M., A. J. Miga, C. L. Vanderlugt, M. C. Dal Canto, J. D. Laman, R. J. Noelle, and S. D. Miller. 1999. Mechanisms of immunotherapeutic intervention by anti-CD40L (CD154) antibody in an animal model of multiple sclerosis. J. Clin. Investig. 103:281-290[Medline]. |
| 17. | Hunter, C. A., L. Ellis-Neyer, K. E. Gabriel, M. K. Kennedy, K. H. Grabstein, P. S. Linsley, and J. S. Remington. 1997. The role of the CD28/B7 interaction in the regulation of NK cell responses during infection with Toxoplasma gondii. J. Immunol. 158:2285-2293[Abstract]. |
| 18. | Infante-Duarte, C., and T. Kamradt. 1999. Th1/Th2 balance in infection. Springer Semin. Immunopathol. 21:317-338[Medline]. |
| 19. | Jouanguy, E., R. Doffinger, S. Dupuis, A. Pallier, F. Altare, and J. L. Casanova. 1999. IL-12 and IFN-gamma in host defense against mycobacteria and salmonella in mice and men. Curr. Opin. Immunol. 11:346-351[CrossRef][Medline]. |
| 20. | Kamanaka, M., P. Yu, T. Yasui, K. Yoshida, T. Kawabe, T. Horii, T. Kishimoto, and H. Kikutani. 1996. Protective role of CD40 in Leishmania major infection at two distinct phases of cell-mediated immunity. Immunity 4:275-281[CrossRef][Medline]. |
| 21. |
Kamijo, R.,
J. Le,
D. Shapiro,
E. A. Havell,
S. Huang,
M. Aguet,
M. Bosland, and J. Vilcek.
1993.
Mice that lack the interferon- receptor have profoundly altered responses to infection with bacillus Calmette-Guerin and subsequent challenge with lipopolysaccharide.
J. Exp. Med.
178:1435-1440 |
| 22. | Kaufmann, S. H., and C. H. Ladel. 1994. Role of T cell subsets in immunity against intracellular bacteria: experimental infections of knock-out mice with Listeria monocytogenes and Mycobacterium bovis BCG. Immunobiology 191:509-519[Medline]. |
| 23. | Kindler, V., A. P. Sappino, G. E. Grau, P. F. Piguet, and P. Vassalli. 1989. The inducing role of tumor necrosis factor in the development of bactericidal granulomas during BCG infection. Cell 56:731-740[CrossRef][Medline]. |
| 24. | King, C. L., J. Xianli, C. H. June, R. Abe, and K. P. Lee. 1996. CD28-deficient mice generate an impaired Th2 response to Schistosoma mansoni infection. Eur. J. Immunol. 26:2448-2455[Medline]. |
| 25. | Kundig, T. M., A. Shahinian, K. Kawai, H. W. Mittrucker, E. Sebzda, M. F. Bachmann, T. W. Mak, and P. S. Ohashi. 1996. Duration of TCR stimulation determines costimulatory requirement of T cells. Immunity 5:41-52[CrossRef][Medline]. |
| 26. | Ladel, C. H., S. Daugelat, and S. H. Kaufmann. 1995. Immune response to Mycobacterium bovis bacille Calmette-Guerin infection in major histocompatibility complex class I- and II-deficient knock-out mice: contribution of CD4 and CD8 T cells to acquired resistance. Eur. J. Immunol. 25:377-384[Medline]. |
| 27. | Ledru, E., S. Ledru, and A. Zoubga. 1999. Granuloma formation and tuberculosis transmission in HIV-infected patients. Immunol. Today 20:336-337[CrossRef][Medline]. |
| 28. | Mendez-Samperio, P., H. E. Ayala-Verdin, and A. Trejo-Echeverria. 1999. Interleukin-12 regulates the production of Bacille Calmette-Guerin-induced interferon-gamma from human cells in a CD40-dependent manner. Scand. J. Immunol. 50:61-67[Medline]. |
| 29. | Metwali, A., D. Elliott, A. M. Blum, J. Li, M. Sandor, R. G. Lynch, N. Noben-Trauth, and J. V. Weinstock. 1996. The granulomatous response in murine schistomiasis mansoni does not switch to TH1 in IL-4-deficient C57BL/6 mice. J. Immunol. 157:4546-4553[Abstract]. |
| 30. |
Murray, P. J.,
R. A. Young, and G. Q. Daley.
1998.
Hematopoietic remodeling in interferon-gamma-deficient mice infected with mycobacteria.
Blood
91:2914-2924 |
| 31. |
Nau, G. J.,
P. Guilfoile,
G. L. Chupp,
J. S. Berman,
S. J. Kim,
H. Kornfeld, and R. A. Young.
1997.
A chemoattractant cytokine associated with granulomas in tuberculosis and silicosis.
Proc. Natl. Acad. Sci. USA
94:6414-6419 |
| 32. |
Ozaki, M. E.,
B. A. Coren,
T. N. Huynh,
D. J. Redondo,
H. Kikutani, and S. R. Webb.
1999.
CD4+ T cell responses to CD40-deficient APCs: defects in proliferation and negative selection apply only with B cells as APCs.
J. Immunol.
163:5250-5256 |
| 33. | Palmieri, F., A. M. Pellicelli, E. Girardi, A. P. De Felici, P. De Mori, N. Petrosillo, and G. Ippolito. 1999. Negative predictors of survival in HIV-infected patients with culture-confirmed pulmonary tuberculosis. Infection 27:331-334[CrossRef][Medline]. |
| 34. | Perlman, D. C., P. El-Helou, and N. Salomon. 1999. Tuberculosis in patients with human immunodeficiency virus infection. Semin. Respir. Infect. 14:344-352[Medline]. |
| 35. |
Reiner, S. L.,
Z. E. Wang,
F. Hatam,
P. Scott, and R. M. Locksley.
1993.
TH1 and TH2 cell antigen receptors in experimental leishmaniasis.
Science
259:1457-1460 |
| 36. | Sacco, R. E., R. J. Jensen, C. O. Thoen, M. Sandor, J. Weinstock, R. G. Lynch, and M. O. Dailey. 1996. Cytokine secretion and adhesion molecule expression by granuloma T lymphocytes in mycobacterium avium infection. Am.J. Pathol. 148:1935-1948[Abstract]. |
| 37. |
Samten, B.,
E. K. Thomas,
J. Gong, and P. F. Barnes.
2000.
Depressed CD40 ligand expression contributes to reduced gamma interferon production in human tuberculosis.
Infect. Immun.
68:3002-3006 |
| 38. | Sandor, M., A. I. Sperling, G. A. Cook, J. V. Weinstock, R. G. Lynch, and J. A. Bluestone. 1995. Two waves of gamma delta T cells expressing different V delta genes are recruited into schistosome-induced liver granulomas. J. Immunol. 155:275-284[Abstract]. |
| 39. | Senaldi, G., S. Yin, C. L. Shaklee, P. Piguet, T. W. Mak, and T. R. Ulich. 1996. Corynebacterium parvum- and Mycobacterium bovis bacillus Calmette-Guerin-induced granuloma formation is inhibited in TNF receptor 1 (TNF-R1) knockout mice and by treatment with soluble TNF-R1. J. Immunol. 157:5022-5026[Abstract]. |
| 40. |
Shahinian, A.,
K. Pfeffer,
K. P. Lee,
T. M. Kundig,
K. Kishihara,
A. Wakeham,
K. Kawai,
P. S. Ohashi,
C. B. Thompson, and T. W. Mak.
1993.
Differential T cell costimulatory requirements in CD28-deficient mice.
Science
261:609-612 |
| 41. |
Skov, S.,
M. Bonyhadi,
N. Odum, and J. A. Ledbetter.
2000.
IL-2 and IL-15 regulate CD154 expression on activated CD4 T cells.
J. Immunol.
164:3500-3505 |
| 42. | Soler, P., V. Boussaud, J. Moreau, A. Bergeron, P. Bonnette, A. J. Hance, and A. Tazi. 1999. In situ expression of B7 and CD40 costimulatory molecules by normal human lung macrophages and epithelioid cells in tuberculoid granulomas. Clin. Exp. Immunol. 116:332-339[CrossRef][Medline]. |
| 43. | Soong, L., J. C. Xu, I. S. Grewal, P. Kima, J. Sun, B. J. Longley Jr, N. H. Ruddle, D. McMahonpratt, and R. A. Flavell. 1996. Disruption of CD40-CD40 ligand interactions results in an enhanced susceptibility to Leishmania amazonensis. Immunity 4:263-273[CrossRef][Medline]. |
| 44. |
Villegas, E. N.,
M. M. Elloso,
G. Reichmann,
R. Peach, and C. A. Hunter.
1999.
Role of CD28 in the generation of effector and memory responses required for resistance to Toxoplasma gondii.
J. Immunol.
163:3344-3353 |
| 45. | Vogel, L. A., and R. J. Noelle. 1998. CD40 and its crucial role as a member of the TNFR family. Semin. Immunol. 10:435-442[CrossRef][Medline]. |
| 46. | Wiley, J. A., and A. G. Harmsen. 1995. CD40 ligand is required for resolution of Pneumocystis carinii pneumonia in mice. J. Immunol. 155:3525-3529[Abstract]. |
| 47. |
Yamauchi, P. S.,
J. R. Bleharski,
K. Uyemura,
J. Kim,
P. A. Sieling,
A. Miller,
H. Brightbill,
K. Schlienger,
T. H. Rea, and R. L. Modlin.
2000.
A role for CD40-CD40 ligand interactions in the generation of type 1 cytokine responses in human leprosy.
J. Immunol.
165:1506-1512 |
| 48. |
Zhou, P., and R. A. Seder.
1998.
CD40 ligand is not essential for induction of type 1 cytokine responses or protective immunity after primary or secondary infection with Histoplasma capsulatum.
J. Exp. Med.
187:1315-1324 |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»